Trial Profile
Phase 2 trial of neoadjuvant chemotherapy with S-1 plus radiation in patients with locally advanced rectal cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Nov 2019
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Adenocarcinoma; Rectal cancer
- Focus Therapeutic Use
- 29 Oct 2019 Status changed from recruiting to completed.
- 10 Apr 2014 New trial record